• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性淋巴细胞白血病经治疗患者CD4 T细胞中STAT3磷酸化增加以及循环调节性T细胞亚群相对于肿瘤肿块分布值和疾病持续时间的变化。

Increased STAT3 Phosphorylation in CD4 T-Cells of Treated Patients with Chronic Lymphocytic Leukemia and Changes in Circulating Regulatory T-Cell Subsets Relative to Tumor Mass Distribution Value and Disease Duration.

作者信息

Dreisinger Mojca, Roškar Zlatko, Goropevšek Aleš, Zakelšek Andreja, Čurič Sara, Živko Nada, Bevc Sebastjan, Homšak Evgenija

机构信息

Department of Haematology, University Medical Centre Maribor, 2000 Maribor, Slovenia.

Department of Laboratory Diagnostics, University Medical Centre Maribor, 2000 Maribor, Slovenia.

出版信息

Biomedicines. 2025 May 15;13(5):1204. doi: 10.3390/biomedicines13051204.

DOI:10.3390/biomedicines13051204
PMID:40427031
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12109142/
Abstract

: In mouse models of chronic lymphocytic leukemia (CLL), an effective anti-leukemia immune response was obtained by depleting a specific regulatory T-cell (Treg) subset. While STAT5 signaling could alter the homeostasis of naïve (nTreg) and activated (aTreg) subsets, which are capable of suppressing also CLL patients' responses to microbial antigens, perturbed STAT3 signaling could drive CXCR5 expression in circulating T-follicular regulatory cells (Tfr) and their entry into the lymph node/tumor microenvironment. : By using phospho-specific flow cytometry, we monitored STAT signaling/phosphorylation (pSTAT), in vitro responses to Sars-Cov2-antigen-specific stimulation, and circulating Treg subsets in relation to Binet stage and total tumor mass/tumor distribution (TTM/TD) scoring in 62 patients with CLL. : The percentage of CXCR5 Treg significantly increased in patients with Binet stage B disease, and Tfr-like subsets were associated with higher TTM and lower TD. The pSTAT3 levels in CD4 T-cells were only significantly increased in patients undergoing therapy. Lower nTreg percentages correlated with increased disease duration, and an increased aTreg/nTreg ratio correlated with SARS-CoV-2-antigen-induced STAT5 signaling responses. : The results show increased amounts of circulating CXCR5 Tfr-like subsets in patients with extensive lymph node involvement and augmented STAT3 signaling in patients on therapy. While STAT5 responses may drive nTreg differentiation into aTreg, nTreg decline is associated with increased disease duration.

摘要

在慢性淋巴细胞白血病(CLL)小鼠模型中,通过消耗特定的调节性T细胞(Treg)亚群获得了有效的抗白血病免疫反应。虽然STAT5信号传导可以改变天然(nTreg)和活化(aTreg)亚群的稳态,这两种亚群也能够抑制CLL患者对微生物抗原的反应,但STAT3信号传导紊乱可能会驱动循环滤泡调节性T细胞(Tfr)中CXCR5的表达及其进入淋巴结/肿瘤微环境。通过使用磷酸特异性流式细胞术,我们监测了62例CLL患者中STAT信号传导/磷酸化(pSTAT)、对Sars-Cov2抗原特异性刺激的体外反应以及与Binet分期和总肿瘤质量/肿瘤分布(TTM/TD)评分相关的循环Treg亚群。Binet分期为B期疾病的患者中CXCR5 Treg的百分比显著增加,Tfr样亚群与较高的TTM和较低的TD相关。仅接受治疗的患者CD4 T细胞中的pSTAT3水平显著增加。较低的nTreg百分比与疾病持续时间增加相关,而aTreg/nTreg比率增加与SARS-CoV-2抗原诱导的STAT5信号反应相关。结果显示,广泛淋巴结受累的患者中循环CXCR5 Tfr样亚群数量增加,接受治疗的患者中STAT3信号增强。虽然STAT5反应可能会驱动nTreg分化为aTreg,但nTreg数量下降与疾病持续时间增加相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2259/12109142/bc9f259ac9bc/biomedicines-13-01204-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2259/12109142/19d65030540f/biomedicines-13-01204-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2259/12109142/fa182fb8bcff/biomedicines-13-01204-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2259/12109142/8da684a21a5a/biomedicines-13-01204-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2259/12109142/bc9f259ac9bc/biomedicines-13-01204-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2259/12109142/19d65030540f/biomedicines-13-01204-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2259/12109142/fa182fb8bcff/biomedicines-13-01204-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2259/12109142/8da684a21a5a/biomedicines-13-01204-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2259/12109142/bc9f259ac9bc/biomedicines-13-01204-g004.jpg

相似文献

1
Increased STAT3 Phosphorylation in CD4 T-Cells of Treated Patients with Chronic Lymphocytic Leukemia and Changes in Circulating Regulatory T-Cell Subsets Relative to Tumor Mass Distribution Value and Disease Duration.慢性淋巴细胞白血病经治疗患者CD4 T细胞中STAT3磷酸化增加以及循环调节性T细胞亚群相对于肿瘤肿块分布值和疾病持续时间的变化。
Biomedicines. 2025 May 15;13(5):1204. doi: 10.3390/biomedicines13051204.
2
Increased Frequency of Circulating Activated FOXP3 Regulatory T Cell Subset in Patients with Chronic Lymphocytic Leukemia Is Associated with the Estimate of the Size of the Tumor Mass, STAT5 Signaling and Disease Course during Follow-Up of Patients on Therapy.慢性淋巴细胞白血病患者循环中活化的FOXP3调节性T细胞亚群频率增加与肿瘤肿块大小的估计、STAT5信号传导以及治疗期间患者随访中的疾病进程相关。
Cancers (Basel). 2024 Sep 22;16(18):3228. doi: 10.3390/cancers16183228.
3
Excessive conversion and impaired thymic output contribute to disturbed regulatory T-cell homeostasis in AIDS patients with low CD4 cell counts.过度转换和胸腺输出受损导致 CD4 计数低的艾滋病患者调节性 T 细胞稳态失调。
AIDS. 2013 Apr 24;27(7):1059-69. doi: 10.1097/QAD.0b013e32835e2b99.
4
New Flow Cytometric Methods for Monitoring STAT5 Signaling Reveal Responses to SARS-CoV-2 Antigen-Specific Stimulation in FOXP3+ Regulatory T Cells also in Patients with Advanced Chronic Lymphocytic Leukemia.新型流式细胞术方法监测 STAT5 信号通路揭示了 SARS-CoV-2 抗原特异性刺激在 FOXP3+调节性 T 细胞中的反应,也揭示了晚期慢性淋巴细胞白血病患者中的反应。
Biosensors (Basel). 2023 May 11;13(5):539. doi: 10.3390/bios13050539.
5
Sirolimus therapy restores the PD-1+ICOS+Tfh:CD45RA-Foxp3 activated Tfr cell balance in primary Sjögren's syndrome.西罗莫司治疗恢复原发性干燥综合征中 PD-1+ICOS+Tfh:CD45RA-Foxp3 激活的 Tfr 细胞平衡。
Mol Immunol. 2022 Jul;147:90-100. doi: 10.1016/j.molimm.2022.04.006. Epub 2022 May 3.
6
The prevalence and function of CD4CXCR5Foxp3 follicular regulatory T cells in diffuse large B cell lymphoma.CD4CXCR5Foxp3 滤泡调节性 T 细胞在弥漫性大 B 细胞淋巴瘤中的流行和功能。
Int Immunopharmacol. 2018 Aug;61:132-139. doi: 10.1016/j.intimp.2018.05.025. Epub 2018 Jun 2.
7
STAT5 phosphorylation in CD4 T cells from patients with SLE is related to changes in their subsets and follow-up disease severity.SLE 患者 CD4 T 细胞中的 STAT5 磷酸化与亚群变化及疾病后续严重程度相关。
J Leukoc Biol. 2017 Jun;101(6):1405-1418. doi: 10.1189/jlb.5A0416-194R. Epub 2017 Mar 2.
8
Activated Galectin-9/Tim3 promotes Treg and suppresses Th1 effector function in chronic lymphocytic leukemia.激活的半乳糖凝集素-9/Tim3 在慢性淋巴细胞白血病中促进 Treg 并抑制 Th1 效应功能。
FASEB J. 2021 Jul;35(7):e21556. doi: 10.1096/fj.202100013R.
9
Increased Levels of STAT1 Protein in Blood CD4 T Cells from Systemic Lupus Erythematosus Patients Are Associated with Perturbed Homeostasis of Activated CD45RAFOXP3 Regulatory Subset and Follow-Up Disease Severity.系统性红斑狼疮患者血液CD4 T细胞中STAT1蛋白水平升高与活化的CD45RAFOXP3调节亚群的内环境稳态紊乱及疾病随访严重程度相关。
J Interferon Cytokine Res. 2017 Jun;37(6):254-268. doi: 10.1089/jir.2016.0040. Epub 2017 Mar 3.
10
Chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemia.慢性淋巴细胞白血病样单克隆 B 细胞淋巴增生症表现出炎症特征增加,而在早期慢性淋巴细胞白血病中则减少。
Exp Hematol. 2021 Mar;95:68-80. doi: 10.1016/j.exphem.2020.12.007. Epub 2021 Jan 7.

本文引用的文献

1
PD-1 suppresses human CD38 circulating Tfr cells and regulates humoral immunity.程序性死亡受体1(PD-1)抑制人类CD38循环滤泡调节性T细胞并调节体液免疫。
J Immunother Cancer. 2025 Jan 11;13(1):e010026. doi: 10.1136/jitc-2024-010026.
2
Increased Frequency of Circulating Activated FOXP3 Regulatory T Cell Subset in Patients with Chronic Lymphocytic Leukemia Is Associated with the Estimate of the Size of the Tumor Mass, STAT5 Signaling and Disease Course during Follow-Up of Patients on Therapy.慢性淋巴细胞白血病患者循环中活化的FOXP3调节性T细胞亚群频率增加与肿瘤肿块大小的估计、STAT5信号传导以及治疗期间患者随访中的疾病进程相关。
Cancers (Basel). 2024 Sep 22;16(18):3228. doi: 10.3390/cancers16183228.
3
The complexities of T-cell dysfunction in chronic lymphocytic leukemia.
慢性淋巴细胞白血病中 T 细胞功能障碍的复杂性。
Semin Hematol. 2024 Jun;61(3):163-171. doi: 10.1053/j.seminhematol.2024.04.001. Epub 2024 Apr 27.
4
Chronic Lymphocytic Leukemia: Disease Biology.慢性淋巴细胞白血病:疾病生物学。
Acta Haematol. 2024;147(1):8-21. doi: 10.1159/000533610. Epub 2023 Sep 16.
5
The role of transcription factors in shaping regulatory T cell identity.转录因子在调节性 T 细胞身份塑造中的作用。
Nat Rev Immunol. 2023 Dec;23(12):842-856. doi: 10.1038/s41577-023-00893-7. Epub 2023 Jun 19.
6
Human T follicular helper clones seed the germinal center-resident regulatory pool.人 T 滤泡辅助细胞克隆为生发中心驻留调节池播种。
Sci Immunol. 2023 Apr 14;8(82):eade8162. doi: 10.1126/sciimmunol.ade8162. Epub 2023 Apr 7.
7
Elevated levels of circulatory follicular T helper cells in chronic lymphocytic leukemia contribute to B cell expansion.慢性淋巴细胞白血病中循环滤泡辅助性 T 细胞水平升高有助于 B 细胞扩增。
J Leukoc Biol. 2023 Mar 1;113(3):305-314. doi: 10.1093/jleuko/qiad006.
8
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
9
Regulatory T cells (Tregs) in lymphoid malignancies and the impact of novel therapies.淋巴恶性肿瘤中的调节性 T 细胞(Tregs)及新型疗法的影响。
Front Immunol. 2022 Aug 1;13:943354. doi: 10.3389/fimmu.2022.943354. eCollection 2022.
10
CD38 as a multifaceted immunotherapeutic target in CLL.CD38作为慢性淋巴细胞白血病中一个多方面的免疫治疗靶点。
Leuk Lymphoma. 2022 Oct;63(10):2265-2275. doi: 10.1080/10428194.2022.2090551. Epub 2022 Aug 17.